Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care: Our Bureau, Mumbai Wednesday, March 18, 2026, 15:40 Hrs [IST] Akums Drugs & Pharmaceutical ...
PITTSBURGH, PA, UNITED STATES, March 20, 2026 /EINPresswire.com/ -- Nina B. of Marietta, GA is the creator of the ...
Researchers found a commercial deworming tablet released only 10% of its drug content in dissolution testing, prompting investigation of new formulations designed to improve drug release and extend ...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
A Consumer Research Report Examining Molecular Hydrogen Tablet Ingredients, Concentration Claims, and How Gundry MD Ultimate ...
Evidence from the UK and other countries shows that most children can learn to swallow tablets. Research has shown that with ...
FDA approves higher 7.2mg Wegovy dose for Novo Nordisk (NVO), showing 20.7% weight loss. April launch aims to challenge Eli ...
Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcomin ...
Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management ...
A recent decision from the U.S. District Court for the District of Delaware highlights an unsuccessful, yet creative Section 101 challenge. This ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results